Latest On InspireMD, Inc (NSPR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-16 17:01 EST | News | InspireMD GAAP EPS of -$0.53 beats by $0.15, revenue of $1.24M beats by $0.24M | N/A |  |
| 2023-05-16 17:01 EST | News | InspireMD, Inc. (NSPR) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-15 13:06 EST | News | InspireMD to raise $113.6M via private placement | N/A | |
| 2023-03-31 08:16 EST | News | InspireMD, Inc. (NSPR) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-30 08:08 EST | News | InspireMD GAAP EPS of $0.60 beats by $1.44, revenue of $1.03M beats by $0.03M | N/A | |
| 2023-03-29 16:11 EST | News | InspireMD Q4 2022 Earnings Preview | N/A | |
| 2023-03-20 16:58 EST | News | InspireMD picks internal candidate for COO role | N/A | |
| 2022-11-08 16:39 EST | News | InspireMD GAAP EPS of -$0.58 beats by $0.15, revenue of $1.43M beats by $0.03M | N/A | |
| 2022-11-08 16:38 EST | News | InspireMD, Inc. (NSPR) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-08-10 03:44 EST | News | InspireMD GAAP EPS of -$0.59 beats by $0.14, revenue of $1.53M beats by $0.33M | N/A | |
| 2022-08-10 03:43 EST | News | InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 05:53 EST | News | InspireMD Q2 2022 Earnings Preview | N/A | |
| 2022-05-11 07:03 EST | News | InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 10:56 EST | News | InspireMD GAAP EPS of -$0.57, revenue of $1.18M | N/A | |
| 2022-03-08 17:32 EST | News | InspireMD GAAP EPS of -$0.53, revenue of $1.38M | N/A | |
| 2022-03-08 17:31 EST | News | InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-07 23:40 EST | News | InspireMD Q4 2021 Earnings Preview | N/A | |
| 2021-11-09 13:50 EST | News | InspireMD EPS beats by $0.24, misses on revenue | N/A | |
| 2021-11-09 13:50 EST | News | InspireMD, Inc. (NSPAR) CEO Marvin Slosman on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-08 16:06 EST | News | InspireMD Q3 2021 Earnings Preview | N/A | |
| 2021-11-02 20:22 EST | News | Warning: NSPR is at high risk of performing badly | N/A | |
| 2021-09-22 01:56 EST | News | InspireMD: Revolutionizing The Field Of Vascular Stenting | N/A | |
| 2021-08-11 05:27 EST | News | InspireMD, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-11 05:27 EST | News | InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-10 08:44 EST | News | InspireMD EPS beats by $0.17, misses on revenue | N/A | |
| 2021-07-23 22:35 EST | News | InspireMD gets enrollment underway in CGuard EPS trial | N/A | |
| 2021-04-27 21:39 EST | News | InspireMD falls as split adjusted NSPR stock begins trading | N/A | |
| 2021-04-15 05:30 EST | News | InspireMD goes into 1-for-15 reverse split | N/A | |
| 2021-03-12 04:19 EST | Analyst Rating | The Analyst Target Price has increased from $0.85 to $1.02. | Buy | |
| 2021-03-10 12:01 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-09 21:02 EST | News | InspireMD EPS misses by $0.03, misses on revenue | N/A | |
| 2021-03-09 21:00 EST | News | InspireMD, Inc.'s (NSPR) CEO Marvin Slosman on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-09 04:14 EST | Earnings Estimate | An EPS average of -$0.16 is estimated for the 2022 year. | Sell | |
| 2021-03-09 04:14 EST | Earnings Estimate | An EPS average of -$0.04 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-02-04 18:42 EST | News | InspireMD shares slide on pricing upsized $18M securities offering | N/A | |
| 2020-11-26 21:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 21:12 EST | Analyst Rating | The Analyst Target Price has decreased from $1.35 to $0.85. | Neutral | |
| 2020-11-10 12:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 04:35 EST | Earnings Estimate | An EPS average of -$0.08 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-09 15:28 EST | News | InspireMD EPS beats by $0.02, beats on revenue | N/A | |
| 2020-11-09 15:25 EST | News | InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 00:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 14:03 EST | Analyst Rating | The Analyst Target Price has decreased from $2 to $1.35. | Neutral | |
| 2020-10-19 10:41 EST | Insider Trade | GARY S ROUBIN has directly acquired 222,223 shares and currently holds 461,173 shares. | Buy | |
| 2020-09-26 13:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-08 20:29 EST | News | InspireMD on go with study of CGuard Carotid Stent system | N/A | |
| 2020-09-02 13:14 EST | Insider Trade | Campbell Rogers has directly acquired 158,033 shares and currently holds 160,635 shares. | Buy | |
| 2020-09-02 13:14 EST | Insider Trade | Paul Stuka has directly acquired 238,950 shares and currently holds 243,606 shares. | Buy | |
About InspireMD, Inc (NSPR):
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
General
- Name InspireMD, Inc
- Symbol NSPR
- Type Common Stock
- Exchange NYSE MKT
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 45
- Last Split Factor1:50
- Last Split Date2019-04-01
- Fiscal Year EndDecember
- IPO Date2011-04-12
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.inspiremd.com
View More
Valuation
- Trailing PE 0.59
- Forward PE 11.7
- Price/Sales (Trailing 12 Mt.) 6.66
- Price/Book (Most Recent Quarter) 7.07
- Enterprise Value Revenue 29.92
- Enterprise Value EBITDA 0.18
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.19
- Next Year EPS Estimate -$0.17
- Next Quarter EPS Estimate -$0.08
- Operating Margin -400%
- Return on Assets -45%
- Return on Equity -120%
- Revenue 2.49 million
- Earnings Per Share -$9.91
- Revenue Per Share $0.11
- Gross Profit 83000
- Quarterly Earnings Growth -84.4%
View More
Highlights
- Market Capitalization 98.15 million
- EBITDA -9352000
- Analyst Target Price $1.02
- Book Value Per Share $0.25
View More
Share Statistics
- Shares Outstanding 117.83 million
- Shares Float 108.09 million
- % Held by Insiders 1203%
- % Held by Institutions 2.82%
- Shares Short 3.6 million
- Shares Short Prior Month 2.57 million
- Short Ratio 0.12
- Short % of Float 3%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 2.13
- 52 Week High $1.48
- 52 Week Low $0.28
- 50 Day Moving Average 0.9
- 200 Day Moving Average 0.52
View More
Dividends
- Dividend Date 2019-04-01
- ExDividend Date N/A
- Dividend Yield 0%
View More
InspireMD, Inc (NSPR) Dividend Calendar:
NSPR's last dividend payment was made to shareholders on April 1, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
InspireMD, Inc (NSPR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-08 | $158000 | -$0.08 | -$0.07 | -23.08% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.06 | -$0.18 | 66.67% |
| 2020-06-30 | 2020-08-05 | $313000 | -$0.20 | -$0.35 | 42.86% |
| 2020-03-31 | 2020-05-11 | $1.03 million | -$0.43 | -$0.63 | 31.75% |
| 2019-12-31 | 2020-03-10 | $1.01 million | -$0.57 | -$0.57 | 0% |
| 2019-09-30 | 2019-11-12 | $939000 | -$1.26 | -$1.35 | 6.67% |
| 2019-06-30 | 2019-08-06 | $1.35 million | -$1.59 | -$2.00 | 20.5% |
| 2019-03-31 | 2019-05-13 | $415000 | -$3.82 | -$2.50 | -52.8% |
| 2018-12-31 | 2019-02-19 | $822000 | -$2.94 | ||
| 2018-09-30 | 2018-11-06 | $769000 | -$166.25 | -$148.75 | -11.76% |
| 2018-06-30 | 2018-08-06 | $1 million | -$166.25 | -$148.75 | -11.76% |
| 2018-03-31 | 2018-05-07 | $1.01 million | -$53.00 | ||
| 2017-12-31 | 2018-02-13 | $834000 | -$50.51 | ||
| 2017-09-30 | 2017-11-07 | $718000 | -$328.09 | ||
| 2017-06-30 | 2017-08-08 | $640000 | -$365.51 | ||
| 2017-03-31 | 2017-05-09 | $569000 | -$1,134.76 | ||
| 2016-12-31 | 2017-02-16 | $322000 | -$1,531.72 | ||
| 2016-09-30 | 2016-11-14 | $469000 | -$1,499.62 | ||
| 2016-06-30 | 2016-08-09 | $540000 | -$166.25 | -$148.75 | -11.76% |
| 2016-03-31 | 2016-05-10 | $563000 | -$10,062.51 | -$15,312.52 | 34.29% |
| 2015-12-31 | 2016-03-28 | $516000 | -$9.25 | -$11.50 | 19.57% |
| 2015-09-30 | 2015-11-09 | $632000 | -$12.00 | -$12.50 | 4% |
| 2015-06-30 | 2015-08-05 | $685000 | -$12.50 | -$12.50 | 0% |
| 2015-03-31 | 2015-05-11 | $477000 | -$25.00 | -$12.50 | -100% |
| 2014-12-31 | 2015-03-12 | $870000 | -$1.20 | -$1.65 | 27.27% |
| 2014-09-30 | 2014-11-12 | $273000 | -$2.00 | -$2.17 | 7.83% |
| 2014-06-30 | 2014-07-23 | $193000 | -$96,250.00 | -$71,458.33 | -34.69% |
| 2014-03-31 | 2014-05-07 | $1.48 million | -$78,750.00 | -$65,625.00 | -20% |
| 2013-12-31 | 2014-02-26 | $1.55 million | -$56,875.00 | -$48,125.00 | -18.18% |
| 2013-09-30 | 2013-11-11 | $1.55 million | -$39,375.00 | -$48,125.00 | 18.18% |
| 2013-06-30 | 2013-09-17 | $1.5 million | -$43,750.00 | -$54,687.50 | 20% |
| 2013-03-31 | 2013-05-08 | $1.51 million | -$74,375.00 | -$87,500.00 | 15% |
| 2012-12-31 | 2013-02-27 | $1.35 million | -$47,294.48 | ||
| 2012-09-30 | 2012-11-02 | $509000 | -$192,500.00 | -$105,000.00 | -83.33% |
| 2012-06-30 | 2012-09-12 | $933000 | -$87,500.00 | -$96,250.00 | 9.09% |
| 2012-03-31 | 2012-05-08 | $1.14 million | -$87,500.00 | -$52,500.00 | -66.67% |
| 2011-12-31 | 2012-03-06 | $1.29 million | -$227,500.00 | $8,750.00 | -2700% |
| 2011-09-30 | 2011-11-15 | $1.99 million | -$70,000.00 | -$52,500.00 | -33.33% |
| 2011-06-30 | 2011-08-31 | $1.04 million | -$61,742.50 | ||
| 2011-03-31 | 2011-06-01 | $1.69 million | -$21,815.18 |
InspireMD, Inc (NSPR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 720000 | N/A | 444000 | 523000 | 522000 |
| Income Before Tax | -3.76 million | N/A | -2.48 million | -1.98 million | -2.53 million |
| Selling General Administrative | 2.61 million | N/A | 1.88 million | 1.79 million | 2.24 million |
| Gross Profit | -390000 | N/A | -120000 | 295000 | 259000 |
| Ebit | -3.76 million | N/A | -2.48 million | -1.97 million | -2.51 million |
| Operating Income | -3.72 million | N/A | -2.45 million | -2.02 million | -2.51 million |
| Income Tax Expense | 4000 | N/A | N/A | N/A | 24000 |
| Total Revenue | 158000 | N/A | 313000 | 1.03 million | 1.01 million |
| Cost of Revenue | 548000 | N/A | 433000 | 739000 | 754000 |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -27000 |
| Net Income From Continuing Operations | -3.77 million | N/A | -2.48 million | -1.98 million | -2.56 million |
| Net Income Applicable to Common Shares | -3.85 million | -2.23 million | -2.48 million | N/A | -2.56 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | -3000 | N/A | N/A |
| Change to Liabilities | -31000 | -104000 | N/A | -41000 | 69000 |
| Total Cash Flow from Investing Activities | -49000 | -31000 | N/A | -69000 | -94000 |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | 12.23 million | 3000 | 4000 | 4.29 million |
| Change to Operating Activities | -852000 | N/A | N/A | 925000 | -62000 |
| Change in Cash | N/A | 10.72 million | -2.37 million | -1.64 million | 2.33 million |
| Total Cash from Operating Activities | -3.04 million | -1.48 million | -2.35 million | -1.57 million | -1.86 million |
| Depreciation | N/A | 37000 | 51000 | 44000 | 41000 |
| Other Cash Flow from Investing Activities | -23000 | -31000 | N/A | -16000 | -28000 |
| Change to Inventory | N/A | -200000 | 34000 | 47000 | -65000 |
| Change to Account Receivables | N/A | N/A | -33000 | -27000 | 65000 |
| Other Cash Flow from Financing Activities | 767000 | N/A | N/A | 1.18 million | 467000 |
| Change to Net Income | 173000 | 51000 | N/A | 41000 | 162000 |
| Capital Expenditures | N/A | N/A | N/A | 53000 | 66000 |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 5.61 million | N/A | 4.53 million | 3.91 million | 4.5 million |
| Total Stockholder Equity | 12.16 million | N/A | 13.21 million | 3.48 million | 5.38 million |
| Other Current Liabilities | N/A | 2.14 million | 17000 | N/A | 2.47 million |
| Total Assets | 17.78 million | N/A | 17.74 million | 7.39 million | 9.88 million |
| Common Stock | 5000 | 3000 | 3000 | N/A | N/A |
| Other Current Assets | 657000 | N/A | 40000 | N/A | N/A |
| Retained Earnings | -168.18 million | -164.32 million | -162.09 million | -159.61 million | -157.63 million |
| Other Liabilities | N/A | 843000 | N/A | N/A | 729000 |
| Other Assets | N/A | 643000 | N/A | N/A | 586000 |
| Cash | 12.65 million | N/A | 13.86 million | 3.14 million | 5.51 million |
| Total Current Liabilities | 3.71 million | 2.57 million | 3.25 million | 2.6 million | 3.12 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 448000 | 1.63 million | 459000 | N/A | 1.48 million |
| Total Current Assets | 15.34 million | 13.34 million | 15.87 million | 5.44 million | 7.81 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 12.16 million | 11.28 million | 13.21 million | N/A | 5.38 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 1.42 million | 1.39 million | 1.4 million | 1.2 million | 1.24 million |
| Accounts Payable | 3.71 million | 427000 | 3.23 million | 562000 | 646000 |
InspireMD, Inc (NSPR) Chart:
InspireMD, Inc (NSPR) News:
Below you will find a list of latest news for InspireMD, Inc (NSPR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
InspireMD, Inc (NSPR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.01 | CALL | 0 | 344 | 74.54 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.3 | CALL | 0 | 77 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.05 | CALL | 0 | 12 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.5 | PUT | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 324.97 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 5.1 | PUT | 0 | 1 | 962.48 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.16 | CALL | 0 | 100 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 358.99 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 265.62 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.2 | CALL | 0 | 33 | 116.44 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0.36 | CALL | 0 | 16 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0.2 | CALL | 0 | 16 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.5 | PUT | 0 | 11 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 178.34 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 172.54 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0.3 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 0 | PUT | 0 | 0 | 127.17 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | PUT | 0 | 0 | 225.32 | TRUE | 0 | 0 |
Latest NSPR Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 4:20 PM EST | 100 | $1.91 |
| Jun 13, 2022 6:45 PM EST | 100 | $1.96 |
InspireMD, Inc (NSPR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1433607/000149315220012512/0001493152-20-012512-index.htm |
| 2019-09-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1433607/000000000019013462/0000000000-19-013462-index.htm |
| 2020-05-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1433607/000000000020004486/0000000000-20-004486-index.htm |
| 2020-07-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1433607/000000000020006389/0000000000-20-006389-index.htm |
| 2020-07-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1433607/000000000020006566/0000000000-20-006566-index.htm |
| 2019-01-17 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000090266419000269/0000902664-19-000269-index.htm |
| 2019-04-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000090266419001850/0000902664-19-001850-index.htm |
| 2020-01-21 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000090266420000309/0000902664-20-000309-index.htm |
| 2018-07-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000091957418004614/0000919574-18-004614-index.htm |
| 2019-09-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000091957419006088/0000919574-19-006088-index.htm |
| 2018-07-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000092189518002079/0000921895-18-002079-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000092189520000261/0000921895-20-000261-index.htm |
| 2020-06-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000092963820000638/0000929638-20-000638-index.htm |
| 2019-04-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000110465919021036/0001104659-19-021036-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000110465920013414/0001104659-20-013414-index.htm |
| 2018-07-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000119312518213199/0001193125-18-213199-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000119312519040198/0001193125-19-040198-index.htm |
| 2019-04-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000121390019006574/0001213900-19-006574-index.htm |
| 2019-10-03 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000121390019019640/0001213900-19-019640-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000121390020003196/0001213900-20-003196-index.htm |
| 2018-06-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1433607/000149315218009395/0001493152-18-009395-index.htm |
| 2018-06-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1433607/000149315218009401/0001493152-18-009401-index.htm |
| 2018-07-03 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315218009640/0001493152-18-009640-index.htm |
| 2018-07-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218009721/0001493152-18-009721-index.htm |
| 2018-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218009806/0001493152-18-009806-index.htm |
| 2018-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218010392/0001493152-18-010392-index.htm |
| 2018-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315218011015/0001493152-18-011015-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218011058/0001493152-18-011058-index.htm |
| 2018-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218012734/0001493152-18-012734-index.htm |
| 2018-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218012949/0001493152-18-012949-index.htm |
| 2018-09-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1433607/000149315218013072/0001493152-18-013072-index.htm |
| 2018-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218013355/0001493152-18-013355-index.htm |
| 2018-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218013906/0001493152-18-013906-index.htm |
| 2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218014222/0001493152-18-014222-index.htm |
| 2018-10-10 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218014318/0001493152-18-014318-index.htm |
| 2018-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218014895/0001493152-18-014895-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315218015226/0001493152-18-015226-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218015246/0001493152-18-015246-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218015715/0001493152-18-015715-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315218016696/0001493152-18-016696-index.htm |
| 2018-11-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218016781/0001493152-18-016781-index.htm |
| 2018-11-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218016854/0001493152-18-016854-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315218017322/0001493152-18-017322-index.htm |
| 2018-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315218017662/0001493152-18-017662-index.htm |
| 2019-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219000354/0001493152-19-000354-index.htm |
| 2019-01-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219000494/0001493152-19-000494-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219000568/0001493152-19-000568-index.htm |
| 2019-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219000813/0001493152-19-000813-index.htm |
| 2019-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219000886/0001493152-19-000886-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001390/0001493152-19-001390-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001456/0001493152-19-001456-index.htm |
| 2019-02-06 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001457/0001493152-19-001457-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001458/0001493152-19-001458-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001459/0001493152-19-001459-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001460/0001493152-19-001460-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001461/0001493152-19-001461-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001462/0001493152-19-001462-index.htm |
| 2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001522/0001493152-19-001522-index.htm |
| 2019-02-08 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001618/0001493152-19-001618-index.htm |
| 2019-02-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1433607/000149315219002225/0001493152-19-002225-index.htm |
| 2019-02-19 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1433607/000149315219002248/0001493152-19-002248-index.htm |
| 2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219002255/0001493152-19-002255-index.htm |
| 2019-02-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1433607/000149315219002284/0001493152-19-002284-index.htm |
| 2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219004101/0001493152-19-004101-index.htm |
| 2019-04-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315219004824/0001493152-19-004824-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219004912/0001493152-19-004912-index.htm |
| 2019-04-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315219004999/0001493152-19-004999-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219005020/0001493152-19-005020-index.htm |
| 2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315219006917/0001493152-19-006917-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219007007/0001493152-19-007007-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219007402/0001493152-19-007402-index.htm |
| 2019-06-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1433607/000149315219009720/0001493152-19-009720-index.htm |
| 2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315219011613/0001493152-19-011613-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219011698/0001493152-19-011698-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219011995/0001493152-19-011995-index.htm |
| 2019-08-23 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219013310/0001493152-19-013310-index.htm |
| 2019-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219013840/0001493152-19-013840-index.htm |
| 2019-09-13 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219014111/0001493152-19-014111-index.htm |
| 2019-09-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1433607/000149315219014112/0001493152-19-014112-index.htm |
| 2019-09-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1433607/000149315219014221/0001493152-19-014221-index.htm |
| 2019-09-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1433607/000149315219014228/0001493152-19-014228-index.htm |
| 2019-09-23 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315219014431/0001493152-19-014431-index.htm |
| 2019-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219014496/0001493152-19-014496-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315219016782/0001493152-19-016782-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219016823/0001493152-19-016823-index.htm |
| 2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219018416/0001493152-19-018416-index.htm |
| 2019-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315219018960/0001493152-19-018960-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315219019329/0001493152-19-019329-index.htm |
| 2020-01-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220000101/0001493152-20-000101-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220000103/0001493152-20-000103-index.htm |
| 2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220000179/0001493152-20-000179-index.htm |
| 2020-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220001204/0001493152-20-001204-index.htm |
| 2020-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220001354/0001493152-20-001354-index.htm |
| 2020-03-10 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1433607/000149315220003630/0001493152-20-003630-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220003648/0001493152-20-003648-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220005813/0001493152-20-005813-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220007151/0001493152-20-007151-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315220008237/0001493152-20-008237-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220008308/0001493152-20-008308-index.htm |
| 2020-05-13 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220008538/0001493152-20-008538-index.htm |
| 2020-05-26 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220009800/0001493152-20-009800-index.htm |
| 2020-05-26 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1433607/000149315220009806/0001493152-20-009806-index.htm |
| 2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220009809/0001493152-20-009809-index.htm |
| 2020-06-01 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010280/0001493152-20-010280-index.htm |
| 2020-06-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010364/0001493152-20-010364-index.htm |
| 2020-06-04 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010569/0001493152-20-010569-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010629/0001493152-20-010629-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010714/0001493152-20-010714-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010852/0001493152-20-010852-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010907/0001493152-20-010907-index.htm |
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220011794/0001493152-20-011794-index.htm |
| 2020-07-02 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1433607/000149315220012512/0001493152-20-012512-index.htm |
| 2020-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220012826/0001493152-20-012826-index.htm |
| 2020-07-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1433607/000149315220013308/0001493152-20-013308-index.htm |
| 2020-07-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1433607/000149315220013519/0001493152-20-013519-index.htm |
| 2020-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220013861/0001493152-20-013861-index.htm |
| 2020-07-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315220014098/0001493152-20-014098-index.htm |
| 2020-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220014100/0001493152-20-014100-index.htm |
| 2020-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220014136/0001493152-20-014136-index.htm |
| 2020-07-29 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315220014176/0001493152-20-014176-index.htm |
| 2020-07-29 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315220014180/0001493152-20-014180-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220014675/0001493152-20-014675-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1433607/000149315220014677/0001493152-20-014677-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220015036/0001493152-20-015036-index.htm |
| 2020-08-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220016150/0001493152-20-016150-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220016998/0001493152-20-016998-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017125/0001493152-20-017125-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017126/0001493152-20-017126-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017127/0001493152-20-017127-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017128/0001493152-20-017128-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017129/0001493152-20-017129-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017131/0001493152-20-017131-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017191/0001493152-20-017191-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017358/0001493152-20-017358-index.htm |
| 2020-09-16 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017883/0001493152-20-017883-index.htm |
| 2020-10-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1433607/000149315220018931/0001493152-20-018931-index.htm |
| 2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220018987/0001493152-20-018987-index.htm |
| 2020-10-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220019534/0001493152-20-019534-index.htm |
| 2020-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220019536/0001493152-20-019536-index.htm |
| 2020-10-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220019600/0001493152-20-019600-index.htm |
| 2020-10-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1433607/000149315220019601/0001493152-20-019601-index.htm |
| 2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000149315220020370/0001493152-20-020370-index.htm |
| 2019-01-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000153561019000011/0001535610-19-000011-index.htm |
| 2019-04-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000153561019000076/0001535610-19-000076-index.htm |
| 2020-01-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000153561020000015/0001535610-20-000015-index.htm |
| 2020-06-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000155335020000520/0001553350-20-000520-index.htm |
| 2020-06-19 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1433607/000155335020000541/0001553350-20-000541-index.htm |
| 2019-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000161577419004318/0001615774-19-004318-index.htm |
| 2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1433607/000161577419004465/0001615774-19-004465-index.htm |
| 2018-06-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1433607/999999999518001676/9999999995-18-001676-index.htm |
| 2019-09-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1433607/999999999519002134/9999999995-19-002134-index.htm |
| 2020-06-02 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1433607/999999999520001314/9999999995-20-001314-index.htm |
InspireMD, Inc (NSPR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of InspireMD, Inc (NSPR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1203%Institutional Ownership: 282%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-11-21 | Thomas J Kester | Director | Sell | 8.00 | 0.21 | 1.68 | 0.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315218016696/0001493152-18-016696-index.htm |
| 2018-12-11 | Paul Stuka | Director | Sell | 65.00 | 0.18 | 11.54 | 12,746.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315218017322/0001493152-18-017322-index.htm |
| 2019-02-04 | Thomas J Kester | Director | Buy | 130,000.00 | 130,000.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001461/0001493152-19-001461-index.htm | ||
| 2019-02-04 | MICHAEL BERMAN | Director | Buy | 130,000.00 | 130,005.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001459/0001493152-19-001459-index.htm | ||
| 2019-02-04 | Campbell Rogers | Director | Buy | 130,000.00 | 130,011.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001462/0001493152-19-001462-index.htm | ||
| 2020-08-31 | Marvin Slosman | CEO and President | Buy | 1,175,287.00 | 1,413,218.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017128/0001493152-20-017128-index.htm | ||
| 2020-08-31 | Campbell Rogers | Director | Buy | 158,033.00 | 160,635.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017125/0001493152-20-017125-index.htm | ||
| 2020-08-31 | MICHAEL BERMAN | Director | Buy | 158,033.00 | 160,635.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017129/0001493152-20-017129-index.htm | ||
| 2020-01-02 | Marvin Slosman | CEO and President | Buy | 182,381.00 | 182,381.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220000103/0001493152-20-000103-index.htm | ||
| 2019-02-04 | James J Barry | President and CEO | Buy | 2,000,000.00 | 2,001,382.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001460/0001493152-19-001460-index.htm | ||
| 2020-08-31 | Thomas J Kester | Director | Buy | 158,033.00 | 210,633.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017127/0001493152-20-017127-index.htm | ||
| 2019-12-16 | James J Barry | President and CEO | Buy | 165,000.00 | 2,166,382.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219019329/0001493152-19-019329-index.htm | ||
| 2019-02-04 | Paul Stuka | Director | Buy | 195,000.00 | 219,999.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001458/0001493152-19-001458-index.htm | ||
| 2020-06-05 | Marvin Slosman | CEO and President | Buy | 55,550.00 | 0.45 | 24,997.50 | 237,931.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010852/0001493152-20-010852-index.htm |
| 2020-08-31 | Paul Stuka | Director | Buy | 238,950.00 | 243,606.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017126/0001493152-20-017126-index.htm | ||
| 2019-02-04 | Craig Shore | CFO AND CAO | Buy | 300,000.00 | 300,532.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315219001390/0001493152-19-001390-index.htm | ||
| 2020-10-16 | GARY S ROUBIN | Director | Buy | 222,223.00 | 0.45 | 100,000.35 | 461,173.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220019601/0001493152-20-019601-index.htm |
| 2020-06-03 | Thomas J Kester | Director | Buy | 50,000.00 | 0.42 | 20,750.00 | 52,600.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220010629/0001493152-20-010629-index.htm |
| 2020-08-31 | Craig Shore | CFO AND CAO | Buy | 678,834.00 | 684,849.00 | https://www.sec.gov/Archives/edgar/data/1433607/000149315220017131/0001493152-20-017131-index.htm |